NCT03095638
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- GSK Investigational Site Austin, Texas, United States
Clinical trial condition
Lentivirus Infections
Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.
5,647 public trials
305 recruiting studies
Lentivirus Infections trial results
NCT01632345
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
Not specified
NCT00878098
- Conditions
- Abortion, Spontaneous, Blood-Borne Infections, Communicable Diseases, +26 more
- Locations
-
- Pretoria Academic Hospital Thulamela Municipality, South Africa
NCT00457665
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +18 more
- Locations
-
- University of Texas Southwestern Medical Center Dallas, Texas, United States
Completed
The SOLVE-IT National Randomized Trial
NCT00653991
- Conditions
- Behavior, Blood-Borne Infections, Communicable Diseases, +15 more
- Locations
-
- University of Southern California (University Village) Los Angeles, California, United States
NCT01686750
- Conditions
- Behavior, Blood-Borne Infections, Communicable Diseases, +20 more
- Locations
-
- YR Gaitonde Center for AIDS Research and Education Chennai, Tamil Nadu, India
NCT03762772
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
- Locations
-
- Clinical Research Center at Eastern Virginia Medical School (NOT RECRUITING ADDITIONAL SITES) Norfolk, Virginia, United States
NCT02842060
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
Completed
Bioequivalence Study of a Fixed-dose Combination (FDC) of Dolutegravir (DTG) and Rilpivirine (RPV)
NCT02741557
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Overland Park, Kansas, United States
NCT01488942
- Conditions
- Behavior, Blood-Borne Infections, Communicable Diseases, +18 more
- Locations
-
- St. Paul's Hospital, VIDUS and Incentives study office site, 611 Powell St. Vancouver, British Columbia, Canada